Research Diagnosis Related Groups (DRG) level LOS quality outcomes for TriStar Centennial Medical Center located at 2300 Patterson St, Nashville, TN, 37203 & includes data from NPIs 1023055126, 1750328852
Dexur analyzed Q3 2017 (July to September 2017) Medicare claims data to benchmark length of stay (LOS) outcomes for TriStar Centennial Medical Center compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 2,348 | 2,257 | ||||||||||
| Surgical | 977 | 950 | ||||||||||
| Non Surgical | 1,371 | 1,307 | ||||||||||
| Cardiovascular | 500 | 480 | ||||||||||
| Orthopedics | 366 | 363 | ||||||||||
| Psychiatry & Mental Disorders | 339 | 328 | ||||||||||
| General Surgery | 204 | 193 | ||||||||||
| General Medicine | 194 | 177 | ||||||||||
| Gastroenterology & Endocrinology | 152 | 149 | ||||||||||
| Urology | 134 | 132 | ||||||||||
| Neurology | 131 | 126 | ||||||||||
| Pulmonology | 89 | 82 | ||||||||||
| Oncology & Hematology | 78 | 74 | ||||||||||
| Spine | 64 | 64 | ||||||||||
| Obstetrics & Gynecology | 44 | 43 | ||||||||||
| Colorectal | 27 | 22 | ||||||||||
| Obesity, Bariatric, Stomach & Duodenal | 18 | 17 |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Coronary Bypass | ||||||||||||
| DRG 236: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 235: CORONARY BYPASS WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 286: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cardiac Valve And Other Major Cardiothoracic Procedures | ||||||||||||
| DRG 219: CARDIAC VALVE AND OTHER MAJOR CARDIOTHORACIC PROCEDURES WITHOUT CARDIAC CATHETERIZATION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Endovascular Procedures | ||||||||||||
| DRG 266: ENDOVASCULAR CARDIAC VALVE REPLACEMENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| DRG 252: OTHER VASCULAR PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Other Circulatory System Diagnoses | ||||||||||||
| Percutaneous Intracardiac Procedures | ||||||||||||
| DRG 274: PERCUTANEOUS INTRACARDIAC PROCEDURES W/O MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Cardiothoracic Procedures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Revision Of Hip Or Knee Replacement | ||||||||||||
| DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
| DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
| Hip And Femur Procedures Except Major Joint |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES | ||||||||||||
| Alcohol/Drug Abuse Or Dependence | ||||||||||||
| DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Organic Disturbances And Intellectual Disability | ||||||||||||
| DRG 884: ORGANIC DISTURBANCES AND INTELLECTUAL DISABILITY |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Major Chest Procedures | ||||||||||||
| DRG 164: MAJOR CHEST PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Other Respiratory System O.R. Procedures | ||||||||||||
| DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Complications Of Treatment |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I. Obstruction | ||||||||||||
| Cholecystectomy | ||||||||||||
| Diabetes |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| Major Male Pelvic Procedures | ||||||||||||
| DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 064: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Disorders Of Nervous System | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA | ||||||||||||
| Seizures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acute Leukemia Without Major Procedure | ||||||||||||
| Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
| DRG 847: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cervical Spinal Fusion | ||||||||||||
| Combined Anterior/Posterior Spinal Fusion |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uterine And Adnexal Procedures For Non-Malignancy |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Small And Large Bowel Procedures |
| Total Hospitalizations (Jul 2017 to Sep 2017) | Total Hospitalizations After Exclusion | Total Users | Avg. LOS | Tennessee Total Hospitalizations (Jul 2017 to Sep 2017) | Tennessee Total Hospitalizations After Exclusion | Tennessee Total Users | Tennessee Avg. LOS | National Total Hospitalizations (Jul 2017 to Sep 2017) | National Total Hospitalizations After Exclusion | National Total Users | National Avg. LOS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stomach, Esophageal And Duodenal Procedures |